Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 70 entries
Sorted by: Best Match Show Resources per page
Irritable bowel syndrome and diet.

Gastroenterology report

Portincasa P, Bonfrate L, de Bari O, Lembo A, Ballou S.
PMID: 28110300
Gastroenterol Rep (Oxf). 2017 Feb;5(1):11-19. doi: 10.1093/gastro/gow047. Epub 2017 Jan 20.

Irritable bowel syndrome (IBS) is a chronic functional disorder of the gastrointestinal tract and is one of the most commonly diagnosed gastrointestinal diseases. The impact of IBS on the general population is large due to its high prevalence, suboptimal...

Cite
Portincasa P, Bonfrate L, de Bari O, et al. Irritable bowel syndrome and diet. Gastroenterol Rep (Oxf). 2017;5(1):11-19doi: 10.1093/gastro/gow047.
Portincasa, P., Bonfrate, L., de Bari, O., Lembo, A., & Ballou, S. (2017). Irritable bowel syndrome and diet. Gastroenterology report, 5(1), 11-19. https://doi.org/10.1093/gastro/gow047
Portincasa, Piero, et al. "Irritable bowel syndrome and diet." Gastroenterology report vol. 5,1 (2017): 11-19. doi: https://doi.org/10.1093/gastro/gow047
Portincasa P, Bonfrate L, de Bari O, Lembo A, Ballou S. Irritable bowel syndrome and diet. Gastroenterol Rep (Oxf). 2017 Feb;5(1):11-19. doi: 10.1093/gastro/gow047. Epub 2017 Jan 20. PMID: 28110300; PMCID: PMC5444258.
Copy Download .nbib Format: NLM
The Role of Dietary Approach in Irritable Bowel Syndrome.

Current medicinal chemistry

Portincasa P, Lembo A, de Bari O, Di Palo DM, Maggio A, Cataldo I, Calamita G.
PMID: 28462704
Curr Med Chem. 2019;26(19):3512-3520. doi: 10.2174/0929867324666170428102451.

Irritable bowel syndrome (IBS) is a chronic functional disorder of the gastrointestinal tract and is one of the most frequent gastrointestinal diseases. In IBS multiple pathophysiological mechanisms including alterations in intestinal motility, permeability, nutrient absorption, and intestinal microbiota have...

Cite
Portincasa P, Lembo A, de Bari O, et al. The Role of Dietary Approach in Irritable Bowel Syndrome. Curr Med Chem. 2019;26(19):3512-3520doi: 10.2174/0929867324666170428102451.
Portincasa, P., Lembo, A., de Bari, O., Di Palo, D. M., Maggio, A., Cataldo, I., & Calamita, G. (2019). The Role of Dietary Approach in Irritable Bowel Syndrome. Current medicinal chemistry, 26(19), 3512-3520. https://doi.org/10.2174/0929867324666170428102451
Portincasa, Piero, et al. "The Role of Dietary Approach in Irritable Bowel Syndrome." Current medicinal chemistry vol. 26,19 (2019): 3512-3520. doi: https://doi.org/10.2174/0929867324666170428102451
Portincasa P, Lembo A, de Bari O, Di Palo DM, Maggio A, Cataldo I, Calamita G. The Role of Dietary Approach in Irritable Bowel Syndrome. Curr Med Chem. 2019;26(19):3512-3520. doi: 10.2174/0929867324666170428102451. PMID: 28462704.
Copy Download .nbib Format: NLM
Research update for articles published in EJCI in 2017.

European journal of clinical investigation

Arellano-Orden E, Bacopoulou F, Baicus C, Bonfrate L, Broadbent J, Buechler C, Carbone F, Charmandari E, Davis GR, Dullaart RPF, Efthymiou V, Goeser F, Goswami N, Jong GP, Lichtenauer M, Liou YS, Lutz P, Maeng M, Mert GÖ, Mert KU, Montecucco F, Ndrepepa G, Olesen KKW, Oliveira P, Perton FG, Portincasa P, Rodriguez-Panadero F, Schernthaner C, Schutte R.
PMID: 31524285
Eur J Clin Invest. 2019 Oct;49(10):e13163. doi: 10.1111/eci.13163. Epub 2019 Sep 16.

No abstract available.

Cite
Arellano-Orden E, Bacopoulou F, Baicus C, et al. Research update for articles published in EJCI in 2017. Eur J Clin Invest. 2019;49(10):e13163doi: 10.1111/eci.13163.
Arellano-Orden, E., Bacopoulou, F., Baicus, C., Bonfrate, L., Broadbent, J., Buechler, C., Carbone, F., Charmandari, E., Davis, G. R., Dullaart, R. P. F., Efthymiou, V., Goeser, F., Goswami, N., Jong, G. P., Lichtenauer, M., Liou, Y. S., Lutz, P., Maeng, M., Mert, G. �. �., Mert, K. U., Montecucco, F., Ndrepepa, G., Olesen, K. K. W., Oliveira, P., Perton, F. G., Portincasa, P., Rodriguez-Panadero, F., Schernthaner, C., & Schutte, R. (2019). Research update for articles published in EJCI in 2017. European journal of clinical investigation, 49(10), e13163. https://doi.org/10.1111/eci.13163
Arellano-Orden, Elena, et al. "Research update for articles published in EJCI in 2017." European journal of clinical investigation vol. 49,10 (2019): e13163. doi: https://doi.org/10.1111/eci.13163
Arellano-Orden E, Bacopoulou F, Baicus C, Bonfrate L, Broadbent J, Buechler C, Carbone F, Charmandari E, Davis GR, Dullaart RPF, Efthymiou V, Goeser F, Goswami N, Jong GP, Lichtenauer M, Liou YS, Lutz P, Maeng M, Mert GÖ, Mert KU, Montecucco F, Ndrepepa G, Olesen KKW, Oliveira P, Perton FG, Portincasa P, Rodriguez-Panadero F, Schernthaner C, Schutte R. Research update for articles published in EJCI in 2017. Eur J Clin Invest. 2019 Oct;49(10):e13163. doi: 10.1111/eci.13163. Epub 2019 Sep 16. PMID: 31524285.
Copy Download .nbib Format: NLM
Histopathological characteristics of synovitis in Familial Mediterranean Fever (FMF).

Joint bone spine

Venerito V, Portincasa P, Stella A, Cazzato G, Cimmino A, Iannone F, Lopalco G.
PMID: 34481942
Joint Bone Spine. 2021 Sep 02;89(2):105259. doi: 10.1016/j.jbspin.2021.105259. Epub 2021 Sep 02.

No abstract available.

Cite
Venerito V, Portincasa P, Stella A, et al. Histopathological characteristics of synovitis in Familial Mediterranean Fever (FMF). Joint Bone Spine. 2021;89(2):105259doi: 10.1016/j.jbspin.2021.105259.
Venerito, V., Portincasa, P., Stella, A., Cazzato, G., Cimmino, A., Iannone, F., & Lopalco, G. (2021). Histopathological characteristics of synovitis in Familial Mediterranean Fever (FMF). Joint bone spine, 89(2), 105259. https://doi.org/10.1016/j.jbspin.2021.105259
Venerito, Vincenzo, et al. "Histopathological characteristics of synovitis in Familial Mediterranean Fever (FMF)." Joint bone spine vol. 89,2 (2021): 105259. doi: https://doi.org/10.1016/j.jbspin.2021.105259
Venerito V, Portincasa P, Stella A, Cazzato G, Cimmino A, Iannone F, Lopalco G. Histopathological characteristics of synovitis in Familial Mediterranean Fever (FMF). Joint Bone Spine. 2021 Sep 02;89(2):105259. doi: 10.1016/j.jbspin.2021.105259. Epub 2021 Sep 02. PMID: 34481942.
Copy Download .nbib Format: NLM
(.

JHEP reports : innovation in hepatology

Molina-Molina E, Shanmugam H, Di Ciaula A, Grattagliano I, Di Palo DM, Palmieri VO, Portincasa P.
PMID: 33490935
JHEP Rep. 2020 Nov 04;3(1):100203. doi: 10.1016/j.jhepr.2020.100203. eCollection 2021 Feb.

BACKGROUND & AIMS: Non-alcoholic fatty liver disease (NAFLD) is characterised by the presence of hepatic steatosis in the absence of other causes of secondary hepatic fat accumulation, and is usually associated with visceral, metabolically active obesity. However, the subclinical...

Cite
Molina-Molina E, Shanmugam H, Di Ciaula A, et al. (. JHEP Rep. 2020;3(1):100203doi: 10.1016/j.jhepr.2020.100203.
Molina-Molina, E., Shanmugam, H., Di Ciaula, A., Grattagliano, I., Di Palo, D. M., Palmieri, V. O., & Portincasa, P. (2021). (. JHEP reports : innovation in hepatology, 3(1), 100203. https://doi.org/10.1016/j.jhepr.2020.100203
Molina-Molina, Emilio, et al. "(." JHEP reports : innovation in hepatology vol. 3,1 (2021): 100203. doi: https://doi.org/10.1016/j.jhepr.2020.100203
Molina-Molina E, Shanmugam H, Di Ciaula A, Grattagliano I, Di Palo DM, Palmieri VO, Portincasa P. (. JHEP Rep. 2020 Nov 04;3(1):100203. doi: 10.1016/j.jhepr.2020.100203. eCollection 2021 Feb. PMID: 33490935; PMCID: PMC7806794.
Copy Download .nbib Format: NLM
Home wound management during the COVID-19 pandemic: The use of a novel adhesive retention suture.

JAAD case reports

Verdura V, Di Pace B, Cagiano L, Portincasa A.
PMID: 33521211
JAAD Case Rep. 2021 Mar;9:67-68. doi: 10.1016/j.jdcr.2021.01.008. Epub 2021 Jan 23.

No abstract available.

Cite
Verdura V, Di Pace B, Cagiano L, et al. Home wound management during the COVID-19 pandemic: The use of a novel adhesive retention suture. JAAD Case Rep. 2021;9:67-68doi: 10.1016/j.jdcr.2021.01.008.
Verdura, V., Di Pace, B., Cagiano, L., & Portincasa, A. (2021). Home wound management during the COVID-19 pandemic: The use of a novel adhesive retention suture. JAAD case reports, 967-68. https://doi.org/10.1016/j.jdcr.2021.01.008
Verdura, Vincenzo, et al. "Home wound management during the COVID-19 pandemic: The use of a novel adhesive retention suture." JAAD case reports vol. 9 (2021): 67-68. doi: https://doi.org/10.1016/j.jdcr.2021.01.008
Verdura V, Di Pace B, Cagiano L, Portincasa A. Home wound management during the COVID-19 pandemic: The use of a novel adhesive retention suture. JAAD Case Rep. 2021 Mar;9:67-68. doi: 10.1016/j.jdcr.2021.01.008. Epub 2021 Jan 23. PMID: 33521211; PMCID: PMC7826136.
Copy Download .nbib Format: NLM
Histopathological characteristics of synovitis in Familial Mediterranean Fever (FMF).

Joint bone spine

Venerito V, Portincasa P, Stella A, Cazzato G, Cimmino A, Iannone F, Lopalco G.
PMID: 34481942
Joint Bone Spine. 2021 Sep 02;89(2):105259. doi: 10.1016/j.jbspin.2021.105259. Epub 2021 Sep 02.

No abstract available.

Cite
Venerito V, Portincasa P, Stella A, et al. Histopathological characteristics of synovitis in Familial Mediterranean Fever (FMF). Joint Bone Spine. 2021;89(2):105259doi: 10.1016/j.jbspin.2021.105259.
Venerito, V., Portincasa, P., Stella, A., Cazzato, G., Cimmino, A., Iannone, F., & Lopalco, G. (2021). Histopathological characteristics of synovitis in Familial Mediterranean Fever (FMF). Joint bone spine, 89(2), 105259. https://doi.org/10.1016/j.jbspin.2021.105259
Venerito, Vincenzo, et al. "Histopathological characteristics of synovitis in Familial Mediterranean Fever (FMF)." Joint bone spine vol. 89,2 (2021): 105259. doi: https://doi.org/10.1016/j.jbspin.2021.105259
Venerito V, Portincasa P, Stella A, Cazzato G, Cimmino A, Iannone F, Lopalco G. Histopathological characteristics of synovitis in Familial Mediterranean Fever (FMF). Joint Bone Spine. 2021 Sep 02;89(2):105259. doi: 10.1016/j.jbspin.2021.105259. Epub 2021 Sep 02. PMID: 34481942.
Copy Download .nbib Format: NLM
Cholesterol and Lipoprotein Metabolism and Atherosclerosis: Recent Advances in Reverse Cholesterol Transport.

Annals of hepatology

Wang HH, Garruti G, Liu M, Portincasa P, Wang DQ.
PMID: 31196632
Ann Hepatol. 2017 Nov;16:S27-S42. doi: 10.5604/01.3001.0010.5495.

Atherosclerosis is characterized by lipid accumulation, inflammatory response, cell death and fibrosis in the arterial wall, and is a major pathological basis for ischemic coronary heart disease (CHD), which is the leading cause of morbidity and mortality in the...

Cite
Wang HH, Garruti G, Liu M, et al. Cholesterol and Lipoprotein Metabolism and Atherosclerosis: Recent Advances in Reverse Cholesterol Transport. Ann Hepatol. 2017;16:S27-S42doi: 10.5604/01.3001.0010.5495.
Wang, H. H., Garruti, G., Liu, M., Portincasa, P., & Wang, D. Q. (2017). Cholesterol and Lipoprotein Metabolism and Atherosclerosis: Recent Advances in Reverse Cholesterol Transport. Annals of hepatology, 16S27-S42. https://doi.org/10.5604/01.3001.0010.5495
Wang, Helen H, et al. "Cholesterol and Lipoprotein Metabolism and Atherosclerosis: Recent Advances in Reverse Cholesterol Transport." Annals of hepatology vol. 16 (2017): S27-S42. doi: https://doi.org/10.5604/01.3001.0010.5495
Wang HH, Garruti G, Liu M, Portincasa P, Wang DQ. Cholesterol and Lipoprotein Metabolism and Atherosclerosis: Recent Advances in Reverse Cholesterol Transport. Ann Hepatol. 2017 Nov;16:S27-S42. doi: 10.5604/01.3001.0010.5495. PMID: 31196632.
Copy Download .nbib Format: NLM
Doing better with functional gastrointestinal disorders? Profiling gut microbiota and circulating antibodies to CdtB and vinculin.

European journal of clinical investigation

Bonfrate L, Di Ciaula A, Portincasa P.
PMID: 34738648
Eur J Clin Invest. 2021 Nov 05;e13702. doi: 10.1111/eci.13702. Epub 2021 Nov 05.

No abstract available.

Cite
Bonfrate L, Di Ciaula A, Portincasa P. Doing better with functional gastrointestinal disorders? Profiling gut microbiota and circulating antibodies to CdtB and vinculin. Eur J Clin Invest. 2021;e13702doi: 10.1111/eci.13702.
Bonfrate, L., Di Ciaula, A., & Portincasa, P. (2021). Doing better with functional gastrointestinal disorders? Profiling gut microbiota and circulating antibodies to CdtB and vinculin. European journal of clinical investigation, e13702. https://doi.org/10.1111/eci.13702
Bonfrate, Leonilde, et al. "Doing better with functional gastrointestinal disorders? Profiling gut microbiota and circulating antibodies to CdtB and vinculin." European journal of clinical investigation vol. (2021): e13702. doi: https://doi.org/10.1111/eci.13702
Bonfrate L, Di Ciaula A, Portincasa P. Doing better with functional gastrointestinal disorders? Profiling gut microbiota and circulating antibodies to CdtB and vinculin. Eur J Clin Invest. 2021 Nov 05;e13702. doi: 10.1111/eci.13702. Epub 2021 Nov 05. PMID: 34738648.
Copy Download .nbib Format: NLM
Doing better with functional gastrointestinal disorders? Profiling gut microbiota and circulating antibodies to CdtB and vinculin.

European journal of clinical investigation

Bonfrate L, Di Ciaula A, Portincasa P.
PMID: 34738648
Eur J Clin Invest. 2022 Jan;52(1):e13702. doi: 10.1111/eci.13702. Epub 2021 Nov 05.

No abstract available.

Cite
Bonfrate L, Di Ciaula A, Portincasa P. Doing better with functional gastrointestinal disorders? Profiling gut microbiota and circulating antibodies to CdtB and vinculin. Eur J Clin Invest. 2021;52(1):e13702doi: 10.1111/eci.13702.
Bonfrate, L., Di Ciaula, A., & Portincasa, P. (2022). Doing better with functional gastrointestinal disorders? Profiling gut microbiota and circulating antibodies to CdtB and vinculin. European journal of clinical investigation, 52(1), e13702. https://doi.org/10.1111/eci.13702
Bonfrate, Leonilde, et al. "Doing better with functional gastrointestinal disorders? Profiling gut microbiota and circulating antibodies to CdtB and vinculin." European journal of clinical investigation vol. 52,1 (2022): e13702. doi: https://doi.org/10.1111/eci.13702
Bonfrate L, Di Ciaula A, Portincasa P. Doing better with functional gastrointestinal disorders? Profiling gut microbiota and circulating antibodies to CdtB and vinculin. Eur J Clin Invest. 2022 Jan;52(1):e13702. doi: 10.1111/eci.13702. Epub 2021 Nov 05. PMID: 34738648.
Copy Download .nbib Format: NLM
COVID-19: Specific and Non-Specific Clinical Manifestations and Symptoms: The Current State of Knowledge.

Journal of clinical medicine

Baj J, Karakuła-Juchnowicz H, Teresiński G, Buszewicz G, Ciesielka M, Sitarz E, Forma A, Karakuła K, Flieger W, Portincasa P, Maciejewski R.
PMID: 32516940
J Clin Med. 2020 Jun 05;9(6). doi: 10.3390/jcm9061753.

Coronavirus disease 2019 (COVID-19), due to the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), has become an epidemiological threat and a worldwide concern. SARS-CoV-2 has spread to 210 countries worldwide and more than 6,500,000 confirmed cases and 384,643 deaths have...

Cite
Baj J, Karakuła-Juchnowicz H, Teresiński G, et al. COVID-19: Specific and Non-Specific Clinical Manifestations and Symptoms: The Current State of Knowledge. J Clin Med. 2020;9(6)doi: 10.3390/jcm9061753.
Baj, J., Karakuła-Juchnowicz, H., Teresiński, G., Buszewicz, G., Ciesielka, M., Sitarz, E., Forma, A., Karakuła, K., Flieger, W., Portincasa, P., & Maciejewski, R. (2020). COVID-19: Specific and Non-Specific Clinical Manifestations and Symptoms: The Current State of Knowledge. Journal of clinical medicine, 9(6), . https://doi.org/10.3390/jcm9061753
Baj, Jacek, et al. "COVID-19: Specific and Non-Specific Clinical Manifestations and Symptoms: The Current State of Knowledge." Journal of clinical medicine vol. 9,6 (2020). doi: https://doi.org/10.3390/jcm9061753
Baj J, Karakuła-Juchnowicz H, Teresiński G, Buszewicz G, Ciesielka M, Sitarz E, Forma A, Karakuła K, Flieger W, Portincasa P, Maciejewski R. COVID-19: Specific and Non-Specific Clinical Manifestations and Symptoms: The Current State of Knowledge. J Clin Med. 2020 Jun 05;9(6). doi: 10.3390/jcm9061753. PMID: 32516940; PMCID: PMC7356953.
Copy Download .nbib Format: NLM
Prevalence of Gastrointestinal Symptoms in Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Results of the Prospective Controlled Multinational GI-COVID-19 Study.

The American journal of gastroenterology

Marasco G, Cremon C, Barbaro MR, Salvi D, Cacciari G, Kagramanova A, Bordin D, Drug V, Miftode E, Fusaroli P, Mohamed SY, Ricci C, Bellini M, Rahman MM, Melcarne L, Santos J, Lobo B, Bor S, Yapali S, Akyol D, Sapmaz FP, Urun YY, Eskazan T, Celebi A, Kacmaz H, Ebik B, Binicier HC, Bugdayci MS, Yağcı MB, Pullukcu H, Kaya BY, Tureyen A, Hatemi İ, Koc ES, Sirin G, Calıskan AR, Bengi G, Alıs EE, Lukic S, Trajkovska M, Hod K, Dumitrascu D, Pietrangelo A, Corradini E, Simren M, Sjolund J, Tornkvist N, Ghoshal UC, Kolokolnikova O, Colecchia A, Serra J, Maconi G, De Giorgio R, Danese S, Portincasa P, Di Stefano M, Maggio M, Philippou E, Lee YY, Venturi A, Borghi C, Zoli M, Gionchetti P, Viale P, Stanghellini V, Barbara G.
PMID: 34751672
Am J Gastroenterol. 2021 Nov 09; doi: 10.14309/ajg.0000000000001541. Epub 2021 Nov 09.

INTRODUCTION: Gastrointestinal (GI) symptoms in coronavirus-19 disease (COVID-19) have been reported with great variability and without standardization. In hospitalized patients, we aimed to evaluate the prevalence of GI symptoms, factors associated with their occurrence, and variation at 1 month.METHODS:...

Cite
Marasco G, Cremon C, Barbaro MR, et al. Prevalence of Gastrointestinal Symptoms in Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Results of the Prospective Controlled Multinational GI-COVID-19 Study. Am J Gastroenterol. 2021;doi: 10.14309/ajg.0000000000001541.
Marasco, G., Cremon, C., Barbaro, M. R., Salvi, D., Cacciari, G., Kagramanova, A., Bordin, D., Drug, V., Miftode, E., Fusaroli, P., Mohamed, S. Y., Ricci, C., Bellini, M., Rahman, M. M., Melcarne, L., Santos, J., Lobo, B., Bor, S., Yapali, S., Akyol, D., Sapmaz, F. P., Urun, Y. Y., Eskazan, T., Celebi, A., Kacmaz, H., Ebik, B., Binicier, H. C., Bugdayci, M. S., Yağcı, M. B., Pullukcu, H., Kaya, B. Y., Tureyen, A., Hatemi, �. �., Koc, E. S., Sirin, G., Calıskan, A. R., Bengi, G., Alıs, E. E., Lukic, S., Trajkovska, M., Hod, K., Dumitrascu, D., Pietrangelo, A., Corradini, E., Simren, M., Sjolund, J., Tornkvist, N., Ghoshal, U. C., Kolokolnikova, O., Colecchia, A., Serra, J., Maconi, G., De Giorgio, R., Danese, S., Portincasa, P., Di Stefano, M., Maggio, M., Philippou, E., Lee, Y. Y., Venturi, A., Borghi, C., Zoli, M., Gionchetti, P., Viale, P., Stanghellini, V., Barbara, G. (2021). Prevalence of Gastrointestinal Symptoms in Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Results of the Prospective Controlled Multinational GI-COVID-19 Study. The American journal of gastroenterology, . https://doi.org/10.14309/ajg.0000000000001541
Marasco, Giovanni, et al. "Prevalence of Gastrointestinal Symptoms in Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Results of the Prospective Controlled Multinational GI-COVID-19 Study." The American journal of gastroenterology vol. (2021). doi: https://doi.org/10.14309/ajg.0000000000001541
Marasco G, Cremon C, Barbaro MR, Salvi D, Cacciari G, Kagramanova A, Bordin D, Drug V, Miftode E, Fusaroli P, Mohamed SY, Ricci C, Bellini M, Rahman MM, Melcarne L, Santos J, Lobo B, Bor S, Yapali S, Akyol D, Sapmaz FP, Urun YY, Eskazan T, Celebi A, Kacmaz H, Ebik B, Binicier HC, Bugdayci MS, Yağcı MB, Pullukcu H, Kaya BY, Tureyen A, Hatemi İ, Koc ES, Sirin G, Calıskan AR, Bengi G, Alıs EE, Lukic S, Trajkovska M, Hod K, Dumitrascu D, Pietrangelo A, Corradini E, Simren M, Sjolund J, Tornkvist N, Ghoshal UC, Kolokolnikova O, Colecchia A, Serra J, Maconi G, De Giorgio R, Danese S, Portincasa P, Di Stefano M, Maggio M, Philippou E, Lee YY, Venturi A, Borghi C, Zoli M, Gionchetti P, Viale P, Stanghellini V, Barbara G. Prevalence of Gastrointestinal Symptoms in Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Results of the Prospective Controlled Multinational GI-COVID-19 Study. Am J Gastroenterol. 2021 Nov 09; doi: 10.14309/ajg.0000000000001541. Epub 2021 Nov 09. PMID: 34751672.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 70 entries